Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX 79430, USA.
National Center for Complementary and Integrative Health, National Institutes of Health, Bethesda, MD 20892, USA.
Cell Rep. 2024 Sep 24;43(9):114669. doi: 10.1016/j.celrep.2024.114669. Epub 2024 Aug 22.
Maladaptive plasticity is linked to the chronification of diseases such as pain, but the transition from acute to chronic pain is not well understood mechanistically. Neuroplasticity in the central nucleus of the amygdala (CeA) has emerged as a mechanism for sensory and emotional-affective aspects of injury-induced pain, although evidence comes from studies conducted almost exclusively in acute pain conditions and agnostic to cell type specificity. Here, we report time-dependent changes in genetically distinct and projection-specific CeA neurons in neuropathic pain. Hyperexcitability of CRF projection neurons and synaptic plasticity of parabrachial (PB) input at the acute stage shifted to hyperexcitability without synaptic plasticity in non-CRF neurons at the chronic phase. Accordingly, chemogenetic inhibition of the PB→CeA pathway mitigated pain-related behaviors in acute, but not chronic, neuropathic pain. Cell-type-specific temporal changes in neuroplasticity provide neurobiological evidence for the clinical observation that chronic pain is not simply the prolonged persistence of acute pain.
适应不良的可塑性与疼痛等疾病的慢性化有关,但急性疼痛向慢性疼痛的转变在机制上还不是很清楚。杏仁中央核(CeA)的神经可塑性已经成为损伤诱导性疼痛的感觉和情感方面的一种机制,尽管这一证据来自几乎完全在急性疼痛条件下进行的研究,并且对细胞类型特异性一无所知。在这里,我们报告了在神经病理性疼痛中,遗传上不同和投射特异性的 CeA 神经元的时变变化。在急性阶段,CRF 投射神经元的过度兴奋和臂旁核(PB)输入的突触可塑性转变为慢性阶段非 CRF 神经元的过度兴奋而没有突触可塑性。因此,化学遗传抑制 PB→CeA 通路减轻了急性而非慢性神经病理性疼痛相关的行为。神经可塑性的细胞类型特异性时变提供了神经生物学证据,证明了临床观察到的慢性疼痛不仅仅是急性疼痛的延长持续存在。